| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.488 | 0.004 | 0.597 | Protein kinase (CK2) alpha inhibitor | 0.597 0.003 DBMET00399 | DBMET00399 | |
| 0.462 | 0.015 | 0.462 | Anticonvulsant | 0.39 0.023 DBMET00399 | ||
| 0.373 | 0.014 | 0.435 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.435 0.008 DBMET00399 | DBMET00399 | |
| 0.347 | 0.004 | 0.454 | Protein kinase (CK2) inhibitor | 0.454 0.003 DBMET00399 | DBMET00399 | |
| 0.385 | 0.068 | 0.552 | MAP kinase kinase 6 inhibitor | 0.552 0.01 DBMET00399 | DBMET00399 | |
| 0.291 | 0.014 | 0.318 | Cyclin-dependent kinase 7 inhibitor | 0.318 0.01 DBMET00399 | DBMET00399 | |
| 0.285 | 0.008 | 0.329 | Death-associated protein kinase 2 inhibitor | 0.329 0.005 DBMET00399 | DBMET00399 | |
| 0.277 | 0.008 | 0.277 | GABA receptor agonist | 0.234 0.012 DBMET00399 | ||
| 0.297 | 0.032 | 0.362 | CDC-like kinase 4 inhibitor | 0.362 0.019 DBMET00399 | DBMET00399 | |
| 0.379 | 0.119 | 0.432 | MAP kinase 1 inhibitor | 0.432 0.087 DBMET00399 | DBMET00399 | |
| 0.276 | 0.02 | 0.29 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.29 0.018 DBMET00399 | DBMET00399 | |
| 0.246 | 0.006 | 0.246 | GABA A receptor agonist | 0.225 0.008 DBMET00399 | ||
| 0.243 | 0.004 | 0.243 | Benzodiazepine agonist | 0.161 0.006 DBMET00399 | ||
| 0.281 | 0.043 | 0.29 | Death-associated protein kinase 3 inhibitor | 0.29 0.04 DBMET00399 | DBMET00399 | |
| 0.276 | 0.045 | 0.364 | Clk dual-specificity kinase inhibitor | 0.364 0.025 DBMET00399 | DBMET00399 | |
| 0.318 | 0.099 | 0.318 | Toll-Like receptor 7 agonist | 0.315 0.101 DBMET00399 | ||
| 0.311 | 0.104 | 0.311 | Toll-Like receptor agonist | 0.307 0.107 DBMET00399 | ||
| 0.253 | 0.047 | 0.283 | TRKC antagonist | 0.283 0.034 DBMET00399 | DBMET00399 | |
| 0.247 | 0.046 | 0.27 | CDC-like kinase 2 inhibitor | 0.27 0.039 DBMET00399 | DBMET00399 | |
| 0.24 | 0.076 | 0.306 | Dyrk kinase inhibitor | 0.306 0.051 DBMET00399 | DBMET00399 | |
| 0.195 | 0.039 | 0.229 | CDC-like kinase 1 inhibitor | 0.229 0.024 DBMET00399 | DBMET00399 | |
| 0.208 | 0.064 | 0.224 | I kappa B kinase epsilon inhibitor | 0.224 0.053 DBMET00399 | DBMET00399 | |
| 0.156 | 0.017 | 0.171 | CDC-like kinase 3 inhibitor | 0.171 0.012 DBMET00399 | DBMET00399 | |
| 0.206 | 0.078 | 0.229 | MAP kinase kinase 2 inhibitor | 0.229 0.064 DBMET00399 | DBMET00399 | |
| 0.136 | 0.01 | 0.136 | GABA A receptor antagonist | 0.054 0.036 DBMET00399 | ||
| 0.145 | 0.024 | 0.265 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.265 0.005 DBMET00399 | DBMET00399 | |
| 0.172 | 0.052 | 0.249 | Glycogen synthase kinase-3 alpha inhibitor | 0.249 0.027 DBMET00399 | DBMET00399 | |
| 0.179 | 0.06 | 0.276 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.276 0.031 DBMET00399 | DBMET00399 | |
| 0.132 | 0.013 | 0.184 | Janus tyrosine kinase 1 inhibitor | 0.184 0.006 DBMET00399 | DBMET00399 | |
| 0.135 | 0.019 | 0.167 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.167 0.011 DBMET00399 | DBMET00399 | |
| 0.14 | 0.023 | 0.207 | Janus tyrosine kinase 2 inhibitor | 0.207 0.011 DBMET00399 | DBMET00399 | |
| 0.142 | 0.029 | 0.171 | CDK2/cyclin A inhibitor | 0.171 0.02 DBMET00399 | DBMET00399 | |
| 0.128 | 0.019 | 0.133 | Syk tyrosine kinase inhibitor | 0.133 0.017 DBMET00399 | DBMET00399 | |
| 0.183 | 0.075 | 0.293 | Tyrosine kinase inhibitor | 0.293 0.044 DBMET00399 | DBMET00399 | |
| 0.199 | 0.093 | 0.271 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.271 0.059 DBMET00399 | DBMET00399 | |
| 0.118 | 0.013 | 0.118 | GABA receptor antagonist | 0.052 0.042 DBMET00399 | ||
| 0.158 | 0.06 | 0.158 | Activin receptor-like kinase 2 inhibitor | 0.152 0.065 DBMET00399 | ||
| 0.144 | 0.046 | 0.236 | Glycogen synthase kinase-3 beta inhibitor | 0.236 0.022 DBMET00399 | DBMET00399 | |
| 0.157 | 0.061 | 0.167 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.167 0.046 DBMET00399 | DBMET00399 | |
| 0.141 | 0.049 | 0.241 | Glycogen synthase kinase-3 inhibitor | 0.241 0.023 DBMET00399 | DBMET00399 | |
| 0.131 | 0.044 | 0.168 | MAP kinase 9 inhibitor | 0.168 0.031 DBMET00399 | DBMET00399 | |
| 0.129 | 0.043 | 0.158 | Activin receptor-like kinase 4 inhibitor | 0.158 0.025 DBMET00399 | DBMET00399 | |
| 0.3 | 0.215 | 0.363 | Antiinflammatory | 0.363 0.163 DBMET00399 | DBMET00399 | |
| 0.128 | 0.046 | 0.285 | MAP kinase kinase kinase inhibitor | 0.285 0.006 DBMET00399 | DBMET00399 | |
| 0.092 | 0.012 | 0.092 | Transforming growth factor beta 1 antagonist | 0.087 0.013 DBMET00399 | ||
| 0.139 | 0.062 | 0.171 | Cyclin-dependent kinase inhibitor | 0.171 0.047 DBMET00399 | DBMET00399 | |
| 0.156 | 0.084 | 0.188 | Cyclin-dependent kinase 3 inhibitor | 0.188 0.042 DBMET00399 | DBMET00399 | |
| 0.186 | 0.117 | 0.208 | Vasodilator | 0.208 0.099 DBMET00399 | DBMET00399 | |
| 0.197 | 0.131 | 0.224 | MAP kinase kinase 3 inhibitor | 0.224 0.067 DBMET00399 | DBMET00399 | |
| 0.114 | 0.05 | 0.225 | Cyclin-dependent kinase 9 inhibitor | 0.225 0.018 DBMET00399 | DBMET00399 | |
| 0.132 | 0.07 | 0.181 | Toll-Like receptor antagonist | 0.181 0.038 DBMET00399 | DBMET00399 | |
| 0.109 | 0.051 | 0.138 | MAP kinase 8 inhibitor | 0.138 0.034 DBMET00399 | DBMET00399 | |
| 0.063 | 0.005 | 0.063 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.152 | 0.095 | 0.282 | LIM domain kinase 1 inhibitor | 0.282 0.025 DBMET00399 | DBMET00399 | |
| 0.143 | 0.087 | 0.2 | Cyclin-dependent kinase 8 inhibitor | 0.2 0.036 DBMET00399 | DBMET00399 | |
| 0.087 | 0.032 | 0.087 | Adenosine A2 receptor antagonist | 0.058 0.051 DBMET00399 | ||
| 0.072 | 0.017 | 0.072 | Adenosine A2b receptor antagonist | 0.049 0.035 DBMET00399 | ||
| 0.101 | 0.047 | 0.147 | Potassium channel activator | 0.147 0.021 DBMET00399 | DBMET00399 | |
| 0.124 | 0.07 | 0.182 | MAP kinase kinase inhibitor | 0.182 0.035 DBMET00399 | DBMET00399 | |
| 0.093 | 0.04 | 0.14 | MAP kinase 11 inhibitor | 0.14 0.02 DBMET00399 | DBMET00399 | |
| 0.148 | 0.097 | 0.248 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.248 0.049 DBMET00399 | DBMET00399 | |
| 0.078 | 0.027 | 0.124 | CDK9/cyclin T1 inhibitor | 0.124 0.014 DBMET00399 | DBMET00399 | |
| 0.083 | 0.035 | 0.101 | Toll-Like receptor 7 antagonist | 0.101 0.021 DBMET00399 | DBMET00399 | |
| 0.074 | 0.028 | 0.093 | Phosphatidylinositol 3-kinase delta inhibitor | 0.093 0.021 DBMET00399 | DBMET00399 | |
| 0.059 | 0.014 | 0.059 | Benzodiazepine antagonist | |||
| 0.091 | 0.047 | 0.172 | I kappa B kinase inhibitor | 0.172 0.011 DBMET00399 | DBMET00399 | |
| 0.094 | 0.052 | 0.125 | Pim-3 kinase inhibitor | 0.125 0.028 DBMET00399 | DBMET00399 | |
| 0.094 | 0.054 | 0.122 | Polo-like kinase-1 inhibitor | 0.122 0.029 DBMET00399 | DBMET00399 | |
| 0.078 | 0.038 | 0.078 | Transforming growth factor antagonist | 0.072 0.046 DBMET00399 | ||
| 0.102 | 0.067 | 0.158 | Cyclin-dependent kinase 2 inhibitor | 0.158 0.035 DBMET00399 | DBMET00399 | |
| 0.087 | 0.053 | 0.124 | MAP-kinase-activated kinase inhibitor | 0.124 0.024 DBMET00399 | DBMET00399 | |
| 0.107 | 0.073 | 0.107 | Acetylcholine release stimulant | |||
| 0.071 | 0.039 | 0.117 | MAP kinase kinase 10 inhibitor | 0.117 0.015 DBMET00399 | DBMET00399 | |
| 0.103 | 0.073 | 0.103 | Cyclin-dependent kinase 5 inhibitor | 0.097 0.078 DBMET00399 | ||
| 0.039 | 0.008 | 0.05 | Protocollagen prolyl hydroxylase inhibitor | 0.05 0.005 DBMET00399 | DBMET00399 | |
| 0.052 | 0.022 | 0.063 | CDK7/cyclin H inhibitor | 0.063 0.014 DBMET00399 | DBMET00399 | |
| 0.195 | 0.166 | 0.251 | Nootropic | 0.251 0.107 DBMET00399 | DBMET00399 | |
| 0.088 | 0.061 | 0.125 | CDK/cyclin complex inhibitor | 0.125 0.039 DBMET00399 | DBMET00399 | |
| 0.107 | 0.08 | 0.207 | TRKA antagonist | 0.207 0.028 DBMET00399 | DBMET00399 | |
| 0.059 | 0.033 | 0.091 | MAP kinase kinase 9 inhibitor | 0.091 0.012 DBMET00399 | DBMET00399 | |
| 0.088 | 0.068 | 0.107 | Uric acid excretion stimulant | 0.107 0.047 DBMET00399 | DBMET00399 | |
| 0.078 | 0.059 | 0.142 | Leucine-rich repeat kinase 2 inhibitor | 0.142 0.023 DBMET00399 | DBMET00399 | |
| 0.089 | 0.071 | 0.111 | MAP kinase kinase 1 inhibitor | 0.111 0.044 DBMET00399 | DBMET00399 | |
| 0.07 | 0.052 | 0.106 | Janus tyrosine kinase 3 inhibitor | 0.106 0.03 DBMET00399 | DBMET00399 | |
| 0.051 | 0.034 | 0.054 | Antiviral (Hepatitis D) | 0.054 0.03 DBMET00399 | DBMET00399 | |
| 0.063 | 0.046 | 0.134 | Tyk2 inhibitor | 0.134 0.017 DBMET00399 | DBMET00399 | |
| 0.111 | 0.096 | 0.14 | Toll-Like receptor 9 antagonist | 0.14 0.07 DBMET00399 | DBMET00399 | |
| 0.019 | 0.005 | 0.037 | Egl nine homolog 2 inhibitor | 0.037 0.004 DBMET00399 | DBMET00399 | |
| 0.055 | 0.042 | 0.055 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.113 | 0.1 | 0.113 | Interleukin 1 antagonist | |||
| 0.122 | 0.11 | 0.203 | Heat shock protein 90 antagonist | 0.203 0.037 DBMET00399 | DBMET00399 | |
| 0.107 | 0.097 | 0.142 | Phosphodiesterase inhibitor | 0.142 0.064 DBMET00399 | DBMET00399 | |
| 0.069 | 0.059 | 0.102 | MAP-kinase-activated kinase 2 inhibitor | 0.102 0.027 DBMET00399 | DBMET00399 | |
| 0.165 | 0.156 | 0.223 | MAP-kinase-activated kinase 5 inhibitor | 0.223 0.079 DBMET00399 | DBMET00399 | |
| 0.055 | 0.046 | 0.08 | Phosphatidylinositol kinase inhibitor | 0.08 0.028 DBMET00399 | DBMET00399 | |
| 0.074 | 0.066 | 0.08 | Phosphodiesterase 3A inhibitor | 0.08 0.056 DBMET00399 | DBMET00399 | |
| 0.095 | 0.088 | 0.101 | Multidrug resistance-associated protein 1 inhibitor | 0.101 0.076 DBMET00399 | DBMET00399 | |
| 0.084 | 0.08 | 0.103 | Bronchodilator | 0.103 0.061 DBMET00399 | DBMET00399 | |
| 0.045 | 0.041 | 0.045 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.062 | 0.059 | 0.08 | MAP kinase kinase 8 inhibitor | 0.08 0.034 DBMET00399 | DBMET00399 | |
| 0.052 | 0.049 | 0.059 | Protein kinase C theta inhibitor | 0.059 0.038 DBMET00399 | DBMET00399 | |
| 0.05 | 0.048 | 0.1 | Glutamate (mGluR1) antagonist | 0.1 0.016 DBMET00399 | DBMET00399 | |
| 0.144 | 0.141 | 0.194 | Focal adhesion kinase 2 inhibitor | 0.194 0.074 DBMET00399 | DBMET00399 | |
| 0.077 | 0.075 | 0.078 | Transforming growth factor beta 3 antagonist | 0.078 0.071 DBMET00399 | DBMET00399 | |
| 0.021 | 0.021 | 0.023 | Phosphodiesterase IX inhibitor | 0.023 0.016 DBMET00399 | DBMET00399 | |
| 0.066 | 0.067 | 0.105 | Glutamate (mGluR) antagonist | 0.105 0.032 DBMET00399 | DBMET00399 | |
| 0.055 | 0.057 | 0.125 | I kappa B kinase 2 inhibitor | 0.125 0.007 DBMET00399 | DBMET00399 | |
| 0.012 | 0.014 | 0.015 | Egl nine homolog 1 inhibitor | 0.015 0.01 DBMET00399 | DBMET00399 | |
| 0.021 | 0.025 | 0.023 | Phosphodiesterase 9A inhibitor | 0.023 0.02 DBMET00399 | DBMET00399 | |
| 0.044 | 0.049 | 0.1 | Toll-Like receptor 8 antagonist | 0.1 0.009 DBMET00399 | DBMET00399 | |
| 0.036 | 0.041 | 0.051 | Phosphodiesterase X inhibitor | 0.051 0.026 DBMET00399 | DBMET00399 | |
| 0.036 | 0.041 | 0.051 | Phosphodiesterase 10A inhibitor | 0.051 0.026 DBMET00399 | DBMET00399 | |
| 0.065 | 0.072 | 0.08 | MAP kinase 10 inhibitor | 0.08 0.051 DBMET00399 | DBMET00399 | |
| 0.032 | 0.042 | 0.066 | Smo receptor antagonist | 0.066 0.017 DBMET00399 | DBMET00399 | |
| 0.044 | 0.056 | 0.054 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.054 0.04 DBMET00399 | DBMET00399 | |
| 0.098 | 0.111 | 0.201 | Tyrosine-protein kinase receptor antagonist | 0.201 0.04 DBMET00399 | DBMET00399 | |
| 0.023 | 0.037 | 0.032 | Glucosylceramidase stimulant | 0.032 0.01 DBMET00399 | DBMET00399 | |
| 0.117 | 0.132 | 0.192 | Heat shock protein 90 alpha antagonist | 0.192 0.055 DBMET00399 | DBMET00399 | |
| 0.048 | 0.064 | 0.076 | Cyclin A2 inhibitor | 0.076 0.035 DBMET00399 | DBMET00399 | |
| 0.196 | 0.212 | 0.359 | GABA C receptor rho-3 antagonist | 0.359 0.081 DBMET00399 | DBMET00399 | |
| 0.061 | 0.078 | 0.081 | Adenosine A3 receptor antagonist | 0.081 0.041 DBMET00399 | DBMET00399 | |
| 0.054 | 0.072 | 0.098 | Check point kinase 1 inhibitor | 0.098 0.029 DBMET00399 | DBMET00399 | |
| 0.045 | 0.065 | 0.057 | Cyclin H inhibitor | 0.057 0.043 DBMET00399 | DBMET00399 | |
| 0.053 | 0.075 | 0.11 | Raf kinase inhibitor | 0.11 0.028 DBMET00399 | DBMET00399 | |
| 0.066 | 0.088 | 0.135 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.135 0.033 DBMET00399 | DBMET00399 | |
| 0.041 | 0.064 | 0.087 | Raf kinase B inhibitor | 0.087 0.026 DBMET00399 | DBMET00399 | |
| 0.052 | 0.075 | 0.094 | MAP kinase 14 inhibitor | 0.094 0.038 DBMET00399 | DBMET00399 | |
| 0.042 | 0.067 | 0.072 | Cyclin A inhibitor | 0.072 0.036 DBMET00399 | DBMET00399 | |
| 0.022 | 0.047 | 0.041 | MAP3K8 inhibitor | 0.041 0.006 DBMET00399 | DBMET00399 | |
| 0.021 | 0.047 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.023 DBMET00399 | DBMET00399 | |
| 0.026 | 0.055 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.024 DBMET00399 | DBMET00399 | |
| 0.052 | 0.085 | 0.076 | Glutamate (mGluR group I) antagonist | 0.076 0.042 DBMET00399 | DBMET00399 | |
| 0.088 | 0.121 | 0.121 | Protein kinase (CK1) inhibitor | 0.121 0.091 DBMET00399 | DBMET00399 | |
| 0.086 | 0.121 | 0.124 | TRKB antagonist | 0.124 0.068 DBMET00399 | DBMET00399 | |
| 0.067 | 0.102 | 0.111 | Pim-1 kinase inhibitor | 0.111 0.048 DBMET00399 | DBMET00399 | |
| 0.083 | 0.119 | 0.125 | RET inhibitor | 0.125 0.075 DBMET00399 | DBMET00399 | |
| 0.033 | 0.07 | 0.052 | Xanthine dehydrogenase inhibitor | 0.052 0.044 DBMET00399 | DBMET00399 | |
| 0.023 | 0.065 | 0.034 | Glutamate (mGluR group II) antagonist | 0.034 0.033 DBMET00399 | DBMET00399 | |
| 0.042 | 0.09 | 0.084 | Fibroblast growth factor 2 antagonist | 0.084 0.031 DBMET00399 | DBMET00399 | |
| 0.049 | 0.099 | 0.091 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.091 0.042 DBMET00399 | DBMET00399 | |
| 0.092 | 0.142 | 0.133 | Src kinase inhibitor | 0.133 0.097 DBMET00399 | DBMET00399 | |
| 0.07 | 0.125 | 0.088 | Xanthine oxidase inhibitor | 0.088 0.075 DBMET00399 | DBMET00399 | |
| 0.022 | 0.08 | 0.039 | ATR kinase inhibitor | 0.039 0.014 DBMET00399 | DBMET00399 | |
| 0.077 | 0.139 | 0.118 | Lck kinase inhibitor | 0.118 0.087 DBMET00399 | DBMET00399 | |
| 0.071 | 0.134 | 0.124 | MAP kinase 13 inhibitor | 0.124 0.052 DBMET00399 | DBMET00399 | |
| 0.047 | 0.111 | 0.063 | I kappa B kinase 1 inhibitor | 0.063 0.06 DBMET00399 | DBMET00399 | |
| 0.045 | 0.109 | 0.074 | Protein kinase B beta inhibitor | 0.074 0.051 DBMET00399 | DBMET00399 | |
| 0.034 | 0.101 | 0.055 | Cyclin A1 inhibitor | 0.055 0.049 DBMET00399 | DBMET00399 | |
| 0.111 | 0.183 | 0.22 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.22 0.067 DBMET00399 | DBMET00399 | |
| 0.022 | 0.099 | 0.041 | MAP3K5 inhibitor | 0.041 0.024 DBMET00399 | DBMET00399 | |
| 0.063 | 0.141 | 0.096 | c-Src kinase inhibitor | 0.096 0.092 DBMET00399 | DBMET00399 | |
| 0.08 | 0.159 | 0.104 | Cathepsin H inhibitor | 0.104 0.099 DBMET00399 | DBMET00399 | |
| 0.076 | 0.157 | 0.113 | Growth factor antagonist | 0.113 0.1 DBMET00399 | DBMET00399 | |
| 0.083 | 0.165 | 0.134 | Protein kinase (CK1) gamma 1 inhibitor | 0.134 0.083 DBMET00399 | DBMET00399 | |
| 0.144 | 0.231 | 0.206 | Hypoxia-inducible factor 1 alpha inhibitor | 0.206 0.145 DBMET00399 | DBMET00399 | |
| 0.069 | 0.157 | 0.098 | mTOR complex 1 inhibitor | 0.098 0.066 DBMET00399 | DBMET00399 | |
| 0.102 | 0.192 | 0.126 | Death-associated protein kinase 1 inhibitor | 0.126 0.094 DBMET00399 | DBMET00399 | |
| 0.054 | 0.146 | 0.091 | Granulocyte macrophage colony stimulating factor antagonist | 0.091 0.084 DBMET00399 | DBMET00399 | |
| 0.093 | 0.189 | 0.155 | Polo-like kinase-3 inhibitor | 0.155 0.079 DBMET00399 | DBMET00399 | |
| 0.024 | 0.126 | 0.046 | mTOR inhibitor | 0.046 0.044 DBMET00399 | DBMET00399 | |
| 0.038 | 0.14 | 0.064 | Aryl hydrocarbon receptor antagonist | 0.064 0.046 DBMET00399 | DBMET00399 | |
| 0.028 | 0.131 | 0.063 | Lysine-specific demethylase 1A inhibitor | 0.063 0.025 DBMET00399 | DBMET00399 | |
| 0.05 | 0.157 | 0.086 | Hepatocyte growth factor antagonist | 0.086 0.067 DBMET00399 | DBMET00399 | |
| 0.043 | 0.154 | 0.08 | Insulin like growth factor 1 antagonist | 0.08 0.061 DBMET00399 | DBMET00399 | |
| 0.023 | 0.136 | 0.058 | p38 MAP kinase inhibitor | 0.058 0.053 DBMET00399 | DBMET00399 | |
| 0.063 | 0.177 | 0.136 | Nav1.6 sodium channel blocker | 0.136 0.072 DBMET00399 | DBMET00399 | |
| 0.028 | 0.144 | 0.057 | Cannabinoid CB1 receptor antagonist | 0.057 0.048 DBMET00399 | DBMET00399 | |
| 0.031 | 0.151 | 0.08 | Fibroblast growth factor 3 antagonist | 0.08 0.051 DBMET00399 | DBMET00399 | |
| 0.066 | 0.189 | 0.128 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.128 0.078 DBMET00399 | DBMET00399 | |
| 0.039 | 0.162 | 0.083 | Insulin growth factor antagonist | 0.083 0.063 DBMET00399 | DBMET00399 | |
| 0.065 | 0.19 | 0.114 | Protein kinase (CK1) gamma inhibitor | 0.114 0.097 DBMET00399 | DBMET00399 | |
| 0.026 | 0.154 | 0.06 | CDC7 inhibitor | 0.06 0.058 DBMET00399 | DBMET00399 | |
| 0.162 | 0.308 | 0.194 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.194 0.184 DBMET00399 | DBMET00399 | |
| 0.035 | 0.183 | 0.106 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.106 0.076 DBMET00399 | DBMET00399 | |
| 0.211 | 0.359 | 0.328 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.328 0.177 DBMET00399 | DBMET00399 | |
| 0.033 | 0.185 | 0.081 | Bcr-Abl kinase inhibitor | 0.081 0.063 DBMET00399 | DBMET00399 | |
| 0.082 | 0.24 | 0.141 | GABA C receptor rho-2 antagonist | 0.141 0.086 DBMET00399 | DBMET00399 | |
| 0.047 | 0.207 | 0.107 | Glutamate receptor antagonist | 0.107 0.088 DBMET00399 | DBMET00399 | |
| 0.065 | 0.226 | 0.127 | Peroxidase inhibitor | 0.127 0.094 DBMET00399 | DBMET00399 | |
| 0.088 | 0.257 | 0.144 | MAP kinase 3 inhibitor | 0.144 0.077 DBMET00399 | DBMET00399 | |
| 0.08 | 0.256 | 0.158 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.158 0.133 DBMET00399 | DBMET00399 | |
| 0.093 | 0.28 | 0.135 | MAP kinase kinase 4 inhibitor | 0.135 0.099 DBMET00399 | DBMET00399 | |
| 0.021 | 0.234 | 0.045 | Potassium channel (ATP-sensitive) activator | 0.045 0.041 DBMET00399 | DBMET00399 | |
| 0.116 | 0.331 | 0.215 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.215 0.14 DBMET00399 | DBMET00399 | |
| 0.022 | 0.238 | 0.047 | Potassium channel (Inward rectifier) activator | 0.047 0.043 DBMET00399 | DBMET00399 | |
| 0.023 | 0.308 | 0.042 | Parathyroid hormone antagonist | 0.042 0.039 DBMET00399 | DBMET00399 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |